Literature DB >> 33396886

Central Serous Chorioretinopathy Classification.

Manuel Vilela1,2, Carolina Mengue2.   

Abstract

Central serous chorioretinopathy is characterized by an idiopathic neurosensory detachment of the retina. This narrative review aims to discuss the classification system used for central serous chorioretinopathy. Based on our current knowledge, there is no universally adopted classification system. This is the result of the unknown aspects related to pathogenesis and clinical spectrum and evolution. The best option could be to aggregate multimodal pieces of information alongside temporal and phenotypic characteristics.

Entities:  

Keywords:  central serous chorioretinopathy; central serous retinopathy; macula; retina

Year:  2020        PMID： 33396886      PMCID： PMC7823356          DOI： 10.3390/ph14010026

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN： 1424-8247


  74 in total

1.  MACULAR DISEASES: CLINICAL MANIFESTATIONS.

Authors:  A E MAUMENEE
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1965 Jul-Aug

2.  Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.

Authors:  Cheolmin Yun; Jungah Huh; So Min Ahn; Boram Lee; Jee Taek Kim; Soon-Young Hwang; Seong-Woo Kim; Jaeryung Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-11-05       Impact factor: 3.117

3.  Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.

Authors:  Pawan Gupta; Vishali Gupta; M R Dogra; Ramandeep Singh; Amod Gupta
Journal:  Int Ophthalmol       Date:  2009-01-30       Impact factor: 2.031

4.  Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.

Authors:  Gülizar Demirok; Fatih Kocamaz; Yasemin Topalak; Yeşim Altay; Ahmet Sengun
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

5.  Albrecht von Graefe (1828-1870) and his contributions to the development of ophthalmology.

Authors:  Milan Ivanišević; Robert Stanić; Petar Ivanišević; Ante Vuković
Journal:  Int Ophthalmol       Date:  2020-01-07       Impact factor: 2.031

Review 6.  Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.

Authors:  Rebecca Kaye; Shruti Chandra; Jay Sheth; Camiel J F Boon; Sobha Sivaprasad; Andrew Lotery
Journal:  Prog Retin Eye Res       Date:  2020-05-11       Impact factor: 21.198

7.  Near-infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy.

Authors:  A Ayata; S Tatlipinar; T Kar; M Unal; D Ersanli; A H Bilge
Journal:  Br J Ophthalmol       Date:  2008-10-01       Impact factor: 4.638

8.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

9.  Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.

Authors:  Maciej Gawęcki; Agnieszka Jaszczuk-Maciejewska; Anna Jurska-Jaśko; Andrzej Grzybowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-22       Impact factor: 3.117

Review 10.  Central Serous Chorioretinopathy: Pathogenesis and Management.

Authors:  Francesco Semeraro; Francesco Morescalchi; Andrea Russo; Elena Gambicorti; Andrea Pilotto; Francesco Parmeggiani; Silvia Bartollino; Ciro Costagliola
Journal:  Clin Ophthalmol       Date:  2019-12-02
View more
  1 in total

1.  The Association Between Circulating Sex Hormones and Central Serous Chorioretinopathy: A Case-Control Study.

Authors:  Chun Zhao; Yan Huang; Xiao-Qiang Liu; Lei Chen; Sheng Ye
Journal:  Ther Clin Risk Manag       Date:  2022-08-25       Impact factor: 2.755
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.